Prevention and Treatment
Edited by James M. Rippe, Theodore J. Angelopoulos
Published May 11th 2012 by CRC Press – 435 pages
The prevalence of obesity in the United States and the rest of the industrialized world has skyrocketed in the past 20 years. Linked to heart disease, diabetes, hypertension, and metabolic syndrome, it is also the leading cause of osteoarthritis and the second leading cause of cancer. With contributions from leading experts in the field, Obesity: Prevention and Treatment bridges the gap between emerging understanding of the pathophysiology of obesity with concrete clinical applications for physicians and other healthcare workers in all disciplines of medicine.
Following an overview of issues related to the prevention and management of obesity, the book discusses:
Currently, over two thirds of the adult population in the United States is either overweight or obese. With these grim statistics, it is critically important that clinicians from all branches of medicine play an active role in diagnosing and treating obesity and its related conditions. This volume arms clinicians with the information they need to create an appropriate prevention and treatment program for their patients.
The Modern Management of Obesity
Preventing and Managing Obesity: The Scope of the Problem; J. M. Rippe and T. J. Angelopoulos
Pathophysiology of Obesity; T. J. Angelopoulos,
Epidemiology of Obesity A. C. Utter, R. R. Suminski, and T. J. Angelopoulos
Identification, Evaluation, and Treatment of Overweight and Obesity; G. A. Bray
Nutritional Aspects of Obesity Management; J. Dwyer and N. Kapur
Exercise Management of the Obese Patient; J. Lowndes and T. J. Angelopoulos
Behavioral Management of the Obese Patient; C. A. Johnston, J. P. Moreno, and J. P. Foreyt
Managing Childhood Obesity; C. A. Johnston and J. P. Moreno
Drug Treatment of Obesity; R. E. Bourey, and C. P. Lambert
Surgical Treatment of Obesity; D. W. Kim and C. Apovian
Obesity and Health: Implications of Public Policy; G. W. Heath
Obesity and Specific Medical Conditions
Obesity and Heart Disease; J. M. Rippe and T. J. Angelopoulos
Obesity and Diabetes; I. G. Fatouros and A. Mitrakou
Obesity and the Metabolic Syndrome; P. W. Grandjean
Obesity and Cancer; C. H. Brown III
Obesity and Arthritis; A. Stavropoulos-Kalinoglou, A. Z. Jamurtas, Y. Koutedakis, and G. D. Kitas
Beyond Subcutaneous Fat; R. L. Seip
James M. Rippe, MD, is a graduate of Harvard College and Harvard Medical School with postgraduate training at Massachusetts General Hospital. He is currently the Founder and Director of the Rippe Lifestyle Institute (RLI), Associate Professor of Medicine (cardiology) at Tufts University School of Medicine, and Professor of Biomedical Sciences at the University of Central Florida, where he also serves as the Chairman of the Center for Lifestyle Medicine. Over the past 20 years, Dr. Rippe has established and run the largest research organization (RLI) in the world, exploring how daily habits and actions impact short- and long-term health and quality of life. This organization has published hundreds of papers that form the scientific basis for the fields of lifestyle medicine and high-performance health. RLI also conducts numerous studies every year on nutrition and healthy weight management.
Theodore J. Angelopoulos, PhD, MPH, is a former scholar of Greece’s National Secretary of Education and has pursued training in exercise physiology and epidemiology at the University of Pittsburgh, Pennsylvania. He also completeda three-year postdoctoral training in metabolism at Washington University School of Medicine in Saint Louis. He is currently a Professor in the Department of Health Professions and Director of the Laboratory of Applied Physiology at the University of Central Florida, Orlando, where he also served as Research Director of the Center for Lifestyle Medicine (2006–2010). Dr. Angelopoulos’ major research areas include metabolism and physiogenomics. He has developed a strong research partnership with the Exercise and Genetics Collaborative Research Group and has received funds from the National Institutes of Health and from industry sponsors.